Search

Amaç: Tüm dünyada olduğu gibi ülkemizde de yaşlı nüfusun artışıyla hemodiyaliz tedavisi alan yaşlı hasta sayısı artmaktadır. Yaşlı hemodiyaliz hastalarında beslenme sorunları mortalite ve morbiditeyi arttırdığı için erken dönemde tanı konulması ve tedaviye başlanması büyük öneme sahiptir. Bu çalışma hemodiyaliz tedavisi alan yaşlı hastalarda yetersiz beslenme prevalansını belirlemek ve Mini Nütrisyonel DeğerlendirmeKısa Formu ile vücut kütle indeksinin beslenme yetersizliği olan hastalardaki etkinliğini değerlendirmek amacıyla yapıldı. Gereç ve Yöntem: Bu kesitsel çalışmaya 65 yaş ve üstü, 66’sı (69,24±5,68) erkek ve 57’si (71.01±7.50) kadın toplam 123 hasta dahil edildi. Hastalara ait antropometrik, klinik ve laboratuvar verilere tıbbi dosyalardan ulaşıldı. Hastalar Mini Nütrisyonel Değerlendirme-Kısa Formu ve vücut kütle indeksi ile değerlendirildi. Bulgular: Mini Nütrisyonel Değerlendirme-Kısa Formuna göre 44 (%35,7) hastada malnütrisyon, 53 (%43,1) hasta malnütrisyon, yönünden riskli, 26 (%21,2) hasta normal beslenme durumu olarak değerlendirildi. Her üç grup arasında vücut ağırlığı ve vücut kitle indeksi açısından istatistiksel olarak anlamlı fark saptandı (sırasıyla; p

Aim: With the increase in the elderly population in our country, as in the whole world, the number of elderly patients receiving hemodialysis treatment is increasing. Since nutritional problemsincrease mortality and morbidity in elderly hemodialysis patients, early diagnosis and initiation of treatment are of great importance. Our aim; In addition to determining the prevalence of malnutrition in elderly patients receiving hemodialysis treatment, we aimed to evaluate the effectiveness of MiniNutritional Assessment-Short Form (MNA-SF) and body mass index (BMI) tests in identifying patients with nutritional deficiency. Materials and Method: A total of 123 patients aged 65 and over, 66 (69.24±5.68) men and 57 (71.01±7.50) women, were included in this cross-sectional study. Anthropometric, clinical and laboratory data of the patients were obtained from medical files. Patients were evaluated with Mini-Nutritional AssessmentShort Form and body mass index. Results: According to Mini-Nutritional Assessment-Short Form, 44 (35.7%) patients were considered malnutrition, 53 (43.1%) patients were at risk for malnutrition, and 26 (21.2%) patients wereconsidered to have a normal nutritional status. A statistically significant difference was found between all three groups in terms of weight and body mass index (respectively; p, Amaç: Tüm dünyada olduğu gibi ülkemizde de yaşlı nüfusun artışıyla hemodiyaliz tedavisi alan yaşlı hasta sayısı artmaktadır. Yaşlı hemodiyaliz hastalarında beslenme sorunları mortalite ve morbiditeyi arttırdığı için erken dönemde tanı konulması ve tedaviye başlanması büyük öneme sahiptir. Bu çalışma hemodiyaliz tedavisi alan yaşlı hastalarda yetersiz beslenme prevalansını belirlemek ve Mini Nütrisyonel DeğerlendirmeKısa Formu ile vücut kütle indeksinin beslenme yetersizliği olan hastalardaki etkinliğini değerlendirmek amacıyla yapıldı. Gereç ve Yöntem: Bu kesitsel çalışmaya 65 yaş ve üstü, 66’sı (69,24±5,68) erkek ve 57’si (71.01±7.50) kadın toplam 123 hasta dahil edildi. Hastalara ait antropometrik, klinik ve laboratuvar verilere tıbbi dosyalardan ulaşıldı. Hastalar Mini Nütrisyonel Değerlendirme-Kısa Formu ve vücut kütle indeksi ile değerlendirildi. Bulgular: Mini Nütrisyonel Değerlendirme-Kısa Formuna göre 44 (%35,7) hastada malnütrisyon, 53 (%43,1) hasta malnütrisyon, yönünden riskli, 26 (%21,2) hasta normal beslenme durumu olarak değerlendirildi. Her üç grup arasında vücut ağırlığı ve vücut kitle indeksi açısından istatistiksel olarak anlamlı fark saptandı (sırasıyla; p

During the unprecedented COVID-19 pandemic, there is insufficient information about the psychological effects and factors that will affect the mental health status of hemodialysis (HD) patients. We aimed to evaluate the psychological effects of the COVID-19 pandemic on HD patients. There is an observational study in secondary-level healthcare services in eastern Turkey. There were a total of 176 respondents. Sociodemographic data of the participants were obtained from the files. All participants were measured with the Fear of COVID-19 Scale (FVC-19S) the depression anxiety and stress scale (DASS-21). There were significant differences between FVC-19S, depression, and anxiety in the age groups (p

Introduction: COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). Materials and Methods: In the present study, 74 patients who admitted to the emergency department with respiratory distress during the pandemic period and received a diagnosis of COVID-19 pneumonia and AHF were included. Laboratory data and radiological findings of the patients, at the time of admission, were evaluated. Result: On admission, there was no difference in age, gender between two groups. However, COVID-19 exposure history was found significantly higher in COVID-19 pneumonia patients group (p

Introduction: Hemodialysis (HD) patients have increased risk for short-term adverse outcomes of COVID-19. However, complications and survival at the post-COVID-19 period have not been published extensively.Methods: We conducted a national, multicenter observational study that included adult maintenance HD patients recovered from confirmed COVID-19. A control HD group without COVID-19 was selected from patients in the same center. We investigated the characteristics and outcomes in the follow-up of HD patients and compare them with the non-COVID-19 group.Results: A total of 1223 patients (635 patients in COVID-19 group, 588 patients in non-COVID-19 group) from 47 centers were included in the study. The patients' baseline and HD characteristics were almost similar. The 28th-day mortality and mortality between 28th day and 90th day were higher in the COVID-19 group than non-COVID-19 group (19 [3.0%] patients vs. none [0%]; 15 [2.4%] patients vs. 4 [0.7%] patients, respectively). The presence of respiratory symptoms, rehospitalization, need for home oxygen therapy, lower respiratory tract infection, and arteriovenous (AV) fistula thrombosis was significantly higher in the COVID-19 group in both the first 28 days and between 28 and 90 days. In the multivariable analysis, age (odds ratio [OR] [95% CI]: 1.029 [1.004-1.056]), group (COVID-19 group vs. non-COVID-19 group) (OR [95% CI]: 7.258 [2.538-20.751]), and vascular access type (tunneled catheter/AV fistula) (OR [95% CI]: 2.512 [1.249-5.051]) were found as independent parameters related to 90-day mortality.Conclusion: In the post-COVID-19 period, maintenance HD patients who have had COVID-19 have increased rehospitalization, respiratory problems, vascular access problems, and high mortality compared with the non-COVID-19 HD patients.

Objective Older adults with co‐morbidities have been reported to be at higher risk for adverse outcomes of coronavirus disease 2019 (COVID‐19). The characteristics of COVID‐19 in older patients and its clinical outcomes in different kidney disease groups are not well known. Methods Data were retrieved from a national multicentric database supported by Turkish Society of Nephrology, which consists of retrospectively collected data between 17 April 2020 and 31 December 2020. Hospitalised patients aged 18 years or older with confirmed COVID‐19 diagnosis suffering from stage 3‐5 chronic kidney disease (CKD) or on maintenance haemodialysis (HD) treatment were included in the database. Non‐uraemic hospitalised patients with COVID‐19 were also included as the control group. Results We included 879 patients [388 (44.1%) female, median age: 63 (IQR: 50‐73) years]. The percentage of older patients in the CKD group was 68.8% (n = 188/273), in the HD group was 49.0% (n = 150/306) and in the control group was 30.4% (n = 70/300). Co‐morbidities were higher in the CKD and HD groups. The rate of presentation with severe‐critical disease was higher in the older CKD and HD groups (43.6%, 55.3% and 16.1%, respectively). Among older patients, the intensive care unit (ICU) admission rate was significantly higher in the CKD and HD groups than in the control group (38.8%, 37.3% and 15.7%, respectively). In‐hospital mortality or death and/or ICU admission rates in the older group were significantly higher in the CKD (29.3% and 39.4%) and HD groups (26.7% and 30.1%) compared with the control group (8.6% and 17.1%). In the multivariate analysis, in‐hospital mortality rates in CKD and HD groups were higher than control group [hazard ratio (HR): 4.33 (95% confidence interval [CI]: 1.53‐12.26) and HR: 3.09 (95% CI: 1.04‐9.17), respectively]. Conclusion Among older COVID‐19 patients, in‐hospital mortality is significantly higher in those with stage 3‐5 CKD and on maintenance HD than older patients without CKD regardless of demographic characteristics, co‐morbidities, clinical and laboratory data on admission.

Objective: The disease caused by Coronavirus 19 is a pandemic disease that emerged at the end of 2019 and has spread worldwide. Although it progresses as a classical upper respiratory tract infection in mild cases, it causes death by causing pneumonia and respiratory distress in severe cases. Although various drugs have been tried, there is still no specific drug treatment. The aim of this study is to investigate the demographic characteristics, risk factors, drugs used and the effects of these drugs on mortality of patients who were infected with Coronavirus 19. Materials and Methods: A total of 71 patients hospitalized in Malatya Training and Research Hospital with the diagnosis of COVID-19 due to positive test results between March 2020 and May 2020 were retrospectively reviewed and recorded from the hospital's database and the Public Health Management System. The demographic characteristics of these patients, the service they were hospitalized, the duration of hospitalization, additional diseases, survival status, and the drugs they used were recorded. statistical analyses were performed by using SPSS (IBM SPSS for Windows, ver.24) and Minitab (Statistical Software for Windows, ver.17) statistical package programs. Results: The number of male patients was statistically significantly higher than female patients (p: 0.001). Mortality rate was higher in males than females (p: 0.001). 73% of the patients had at least one additional disease. The most common additional disease was hypertension (48%). The mortality rate of patients with comorbidities was statistically significantly higher than those without (p: 0.001). In our institution 5 drug groups, including hydroxychloroquine, oseltamivir, azithromycin, favipiravir, ritonavir and lopinavir have been were routinely used against COVID-19. The most frequently used drug was hydroxychloroquine (77%). The drugs used had no effect on mortality (p: 0.582). Conclusion: The results of our study indicate that the majority of those who get COVID 19 are men, age is an important risk factor, additional diseases increase the risk of mortality, and all the drugs used have no effect on mortality Amaç: Corona Virüs 19’un neden olduğu hastalık, 2019 yılının sonunda ortaya çıkan halen Dünya genelinde yaygın olarak görülen pandemik hastalıktır. Hafif vakalarda klasik bir üst solunum enfeksiyonu şeklinde seyretse de ağır vakalarda pnömoni ve solumun sıkıntısına yol açarak ölüme neden olur. Günümüzde halan spesifik bir ilaç tedavisi bulunmamakta ve çeşitli ilaçlar tedavi için denenmektedir. Bu çalışmada, Corona Virüs 19’a yakalanan hastaların demografik özellikleri, risk faktörleri, kullanılan ilaçlar ve bu ilaçların mortalite üzerine etkilerinin araştırılması amaçlandı. Materyal ve Metot: Malatya Eğitim ve Araştırma Hastanesi’nde 2020 yılı Mart-Mayıs ayları arasında Covid 19 tanısı ile yatan ve test sonucu pozitif olan toplam 71 hasta, hastanenin veri tabanından ve Halk Sağlığı Yönetim Sisteminden retrospektif olarak taranarak kaydedildi. Bu hastaların, demografik özellikleri, yattıkları servis, yatış süreleri, ek hastalıkları, sağ kalım durumları, kullandıkları ilaçlar tespit edildi. İstatiksel analiz için SPSS (IBM SPSS for Windows, ver.24) ve Minitab (Statistical Software for Windows, ver.17) istatistik paket programları kullanılmıştır. Bulgular: Erkek hastaların sayısı kadınlara göre istatiksel anlamlı olarak yüksekti (p: 0.001). Ölüm oranı erkeklerde kadınlara göre daha yüksekti (p:0,001). Hastaların %73’ünde en az bir ek hastalık vardı. En fazla görülen ek hastalık hipertansiyondu (%48). Ek hastalığı olan hastaların ölüm oranı olmayanlara göre istatiksel anlamlı olarak yüksekti (p: 0.001). Hastanemizde Covid 19’a karşı rutin olarak hidroksiklorokin, oseltamivir, azitromisin, favipiravir, ritonavir ve lopinavir olmak üzere beş ilaç grubu kullanılmıştı. Bu ilaçlar içerisinden en fazla kullanılan hidroksiklorokin’di (%77). Kullanılan ilaçların mortalite üzerine herhangi bir etkisi yoktu (p: 0.582). Sonuç: Çalışmamızın sonuçları, Covid 19 hastalığına yakalananların çoğunluğunun erkek olduğunu, yaşın önemli bir risk faktörü olduğunu, ek hastalıkların mortalite riskini artırdığını, kullanılan bütün ilaçların mortalite üzerinde herhangi bir etkisinin olmadığını göstermektedir.